Skip to main content

Exact Sciences to Participate in May Investor Conference

Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will participate in the following conference and invited investors to participate by webcast.

  • BofA Securities Health Care Conference, Las Vegas

    Fireside chat on Wednesday, May 15, 2024 at 4:40 p.m. ET

The webcast can be accessed in the investor relations section of Exact Sciences’ website at www.exactsciences.com.

About Exact Sciences Corp.

A leading provider of cancer screening and diagnostic tests, Exact Sciences gives patients and health care professionals the clarity needed to take life-changing action earlier. Building on the success of the Cologuard® and Oncotype® tests, Exact Sciences is investing in its pipeline to develop innovative solutions for use before, during, and after a cancer diagnosis. For more information, visit ExactSciences.com, follow Exact Sciences on X (formerly known as Twitter) @ExactSciences, or find Exact Sciences on LinkedIn and Facebook.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  249.11
+9.22 (3.84%)
AAPL  258.52
-0.68 (-0.26%)
AMD  254.90
+8.07 (3.27%)
BAC  53.34
-0.01 (-0.02%)
GOOG  329.34
+10.13 (3.17%)
META  661.58
+27.05 (4.26%)
MSFT  392.31
+7.94 (2.07%)
NVDA  196.16
+6.84 (3.62%)
ORCL  162.41
+6.79 (4.36%)
TSLA  365.52
+13.10 (3.72%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.